BlackRock Investment Management, LLC - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 352 filers reported holding SALIX PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.50 and the average weighting 0.4%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$31,087,000
+42.9%
179,891
-5.0%
0.04%
+41.4%
Q4 2014$21,757,000
-24.1%
189,290
+3.1%
0.03%
-27.5%
Q3 2014$28,683,000
-11.1%
183,586
-29.9%
0.04%
-7.0%
Q2 2014$32,282,000
+79.4%
261,710
+50.7%
0.04%
+65.4%
Q1 2014$17,996,000
+14.2%
173,687
-0.8%
0.03%
+13.0%
Q4 2013$15,752,000
+35.5%
175,139
+0.7%
0.02%
+21.1%
Q3 2013$11,626,000
+264.5%
173,841
+260.4%
0.02%
+216.7%
Q2 2013$3,190,00048,2290.01%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 300,000$46,872,00024.29%
HealthCor Management, L.P. 935,100$146,100,0007.50%
1492 Capital Management LLC 70,167$10,963,0006.07%
Visium Asset Management, LP 2,301,629$359,607,0005.31%
HWG Holdings LP 39,621$6,190,0004.97%
Riggs Asset Managment Co. Inc. 45,649$7,132,0004.14%
Cardinal Capital Management 49,139$7,677,0003.65%
AMI ASSET MANAGEMENT CORP 213,398$33,341,0003.27%
BENNETT LAWRENCE MANAGEMENT L L C/NY 88,435$13,817,0003.14%
Adamant Biomedical Investments AG 78,210$12,220,0003.05%
View complete list of SALIX PHARMACEUTICALS INC shareholders